Inflammatory bowel disease
- PMID: 16632672
- PMCID: PMC2082730
- DOI: 10.1136/adc.2005.080481
Inflammatory bowel disease
Abstract
Twenty five per cent of inflammatory bowel disease presents in childhood. Growth and nutrition are key issues in the management with the aim of treatment being to induce and then maintain disease remission with minimal side effects. Only 25% of Crohn's disease presents with the classic triad of abdominal pain, weight loss, and diarrhoea. Most children with ulcerative colitis have blood in the stool at presentation. Inflammatory markers are usually although not invariably raised at presentation (particularly in Crohn's disease). Full investigation includes upper gastrointestinal endoscopy and ileocolonoscopy. Treatment requires multidisciplinary input as part of a clinical network led by a paediatrician with special expertise in the management of the condition.
Conflict of interest statement
Competing interests: none declared
References
-
- Loftus E V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 20041261504–1517. - PubMed
-
- Sartor R B. Role of commensal enteric bacteria in the pathogenesis of immune‐mediated intestinal inflammation: lessons from animal models and implications for translational research. J Pediatr Gastroenterol Nutr 200540(suppl 1)S30–S31. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources